Impact of alcohol habits and smoking on the risk of new-onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy: The LIFE Study

被引:15
|
作者
Ariansen, Inger [1 ]
Reims, Henrik M. [2 ]
Gjesdal, Knut [1 ,3 ]
Olsen, Michael Hecht [4 ]
Ibsen, Hans [5 ]
Devereux, Richard B. [6 ]
Okin, Peter M. [6 ]
Kjeldsen, Sverre E. [1 ,3 ]
Dahlof, Bjorn [7 ]
Wachtell, Kristian [8 ]
机构
[1] Univ Oslo, Ulleval Hosp, Dept Cardiol, Oslo, Norway
[2] Univ Oslo, Ulleval Hosp, Dept Pathol, Oslo, Norway
[3] Univ Oslo, Oslo, Norway
[4] Glostrup Univ Hosp, Dept Internal Med, Copenhagen, Denmark
[5] Holbaek Cent Hosp, Div Cardiol, Holbaek, Denmark
[6] Weill Cornell Med Coll, Greenberg Div Cardiol, New York, NY USA
[7] Sahlgrens Univ Hosp, Dept Internal Med, Gothenburg, Sweden
[8] Univ Copenhagen, Rigshosp, Ctr Heart, Dept Cardiol, DK-2100 Copenhagen, Denmark
关键词
arrhythmia; Cornell voltage-duration product; ethanol; Sokolow-Lyon; HEART-RATE-VARIABILITY; END-POINT REDUCTION; LOSARTAN INTERVENTION; ADRENERGIC ACTIVITY; CARDIAC-RHYTHM; CONSUMPTION; MEN; METAANALYSIS; ATENOLOL; COHORT;
D O I
10.3109/08037051.2011.622978
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background. The incidence of new-onset atrial fibrillation (AF) is increased by uncontrolled hypertension, and antihypertensive treatment reduces new-onset AF. However, it is unclear whether alcohol intake and smoking influence the risk of new-onset AF during antihypertensive treatment. Methods. In the Losartan Intervention F or Endpoint reduction in Hypertension (LIFE) study, a double-blinded, randomized, parallel-group study, 9193 hypertensive patients with electrocardiogram (ECG)-documented left ventricular hypertrophy (LVH), randomized to once-daily losartan- or atenolol-based antihypertensive therapy were followed for a mean of 4.8 years. At baseline, 8831 patients (54% women, mean age 67 years, mean blood pressure 174/98 mmHg after placebo run-in) had neither a history of AF nor AF on ECG, and they were thus at risk of developing this condition during the study. Results. New-onset AF occurred in 353 (4%) patients. Univariate Cox analyses showed that intake of alcohol > 10 units/week compared with less or no alcohol intake predicted new-onset AF (Hazard ratio, HR = 1.60 [95% CI 1.02-2.51], p = 0.043). Multivariate Cox regression analysis showed that intake of alcohol > 10 units/week predicted new-onset AF (p = 0.010) independently of most other univariate predictors, except when also baseline serum cholesterol, serum potassium and urinary albumin/creatinine ratio were included in the model (HR = 1.60 [95% CI 0.94-2.72], p = 0.081). Impact of smoking was not significant in Cox univariate or multivariate analyses, and there were no significant interactions between high alcohol intake and either smoking or gender on the risk of getting AF. Conclusions. Up to 10 drinks of alcohol per week appears to be safe with respect to the risk for AF in hypertensive patients with LVH. Our data suggest that alcohol intake above this level may be marginally deleterious, while no effect of smoking on risk of AF was detected in hypertensive patients with LVH.
引用
收藏
页码:6 / 11
页数:6
相关论文
共 50 条
  • [21] Atrial fibrillation is an independent risk factor for new-onset myocardial infarction: a prospective study
    Wu, Jianmei
    Hou, Qiqi
    Han, Quanle
    Mao, Ruiying
    Yue, Bocheng
    Yu, Jing
    Chen, Shuohua
    Wu, Shouling
    Li, Kangbo
    ACTA CARDIOLOGICA, 2023, 78 (03) : 341 - 348
  • [22] Autonomic Dysfunction and New-Onset Atrial Fibrillation in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: A CARISMA Substudy
    Jons, Christian
    Raatikainen, Pekka
    Gang, Uffe J.
    Huikuri, Heikki V.
    Joergensen, Rikke Moerch
    Johannesen, Arne
    Dixen, Ulrik
    Messier, Marc
    McNitt, Scott
    Thomsen, Poul Erik Bloch
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2010, 21 (09) : 983 - 990
  • [23] Risk Factors for New-Onset Atrial Fibrillation in the General Population and Patients Who Visit Hospital
    Kodani, Eitaro
    CIRCULATION JOURNAL, 2018, 82 (09) : 2242 - 2243
  • [24] The impact of body weight and diabetes on new-onset atrial fibrillation: a nationwide population based study
    Kim, Yun Gi
    Han, Kyung-Do
    Choi, Jong-Il
    Boo, Ki Yung
    Kim, Do Young
    Oh, Suk-Kyu
    Lee, Kwang-No
    Shim, Jaemin
    Kim, Jin Seok
    Kim, Young-Hoon
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (01)
  • [25] Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapy
    Chung, Yi-Wei
    Yang, Yao-Hsu
    Wu, Cho-Kai
    Yu, Chih-Chieh
    Juang, Jyh-Ming Jimmy
    Wang, Yi-Chih
    Tsai, Chia-Ti
    Lin, Lian-Yu
    Lai, Ling-Ping
    Hwang, Juey-Jen
    Chiang, Fu-Tien
    Chen, Pau-Chung
    Lin, Jiunn-Lee
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 202 : 962 - 966
  • [26] Impact of anti-arrhythmic drugs and catheter ablation on the survival of patients with atrial fibrillation: a population study based on 199 433 new-onset atrial fibrillation patients in the UK
    Chung, Sheng-Chia
    Lai, Alvina
    Lip, Gregory Y. H.
    Lambiase, Pier D.
    Providencia, Rui
    EUROPACE, 2023, 25 (02): : 351 - 359
  • [27] Regression of ECG-LVH is Associated with Lower Risk of New-Onset Heart Failure and Mortality in Patients with Isolated Systolic Hypertension; The LIFE Study
    Larstorp, Anne Cecilie K.
    Okin, Peter M.
    Devereux, Richard B.
    Olsen, Michael H.
    Ibsen, Hans
    Dahlof, Bjorn
    Kjeldsen, Sverre E.
    Wachtell, Kristian
    AMERICAN JOURNAL OF HYPERTENSION, 2012, 25 (10) : 1101 - 1109
  • [28] Association of left bundle branch block with new onset abnormal wall motion in treated hypertensive patients with left ventricle hypertrophy: the LIFE Echo Sub-study
    Stokke, Ildri M.
    Li, Zhi Bin
    Cicala, Silvana
    Okin, Peter M.
    Kjeldsen, Sverre E.
    Devereux, Richard B.
    Wachtell, Kristian
    BLOOD PRESSURE, 2019, 28 (02) : 84 - 92
  • [29] Comparison of risk profiles for new-onset atrial fibrillation between patients aged <60 and ≥60 years
    Kim, In-Soo
    Choi, Yeon-Jik
    Choi, Eui-Young
    Min, Pil-Ki
    Yoon, Young Won
    Lee, Byoung Kwon
    Hong, Bum-Kee
    Rim, Se-Joong
    Kwon, Hyuck Moon
    Kim, Jong-Youn
    PLOS ONE, 2021, 16 (11):
  • [30] Long-term effect of antihypertensive drugs on the risk of new-onset atrial fibrillation: a longitudinal cohort study
    Jong, Gwo-Ping
    Chen, Hung-Yi
    Li, Shu-Yi
    Liou, Yi-Sheng
    HYPERTENSION RESEARCH, 2014, 37 (10) : 950 - 953